Nut allergies develop when the immune system mistakenly identifies proteins in peanuts or tree nuts as dangerous and launches an aggressive inflammatory response. About 6.2 million Americans are allergic to peanuts and another 3.9 million to tree nuts, and those numbers have more than tripled in children between 1997 and 2008. The causes involve a combination of genetic predisposition, how and when the immune system first encounters nut proteins, and environmental factors that shape immune development early in life.
How the Immune System Overreacts
A nut allergy is driven by a specific type of antibody called IgE. In people with the allergy, immune cells encounter nut proteins and begin producing IgE antibodies tailored to those proteins. These antibodies attach to mast cells and another type of immune cell called basophils, essentially arming them. This is the sensitization phase, and it happens without symptoms. You can eat nuts many times before the allergy reveals itself.
The reaction happens on re-exposure. When nut proteins enter the body again, they latch onto the IgE antibodies already sitting on mast cells. This cross-linking triggers the cells to release a flood of inflammatory chemicals: histamine, prostaglandins, tryptase, and platelet-activating factor. These mediators are what cause the actual symptoms, from hives and swelling to breathing difficulty and, in severe cases, anaphylaxis. The whole cascade can unfold within minutes.
Genetics Play a Major Role
Nut allergies run strongly in families. A child with a parent or sibling who has peanut allergy faces a sevenfold increase in risk compared to the general population. Among relatives of people with peanut allergy, the rate is about 7%, versus 0.5% in the broader population. Twin studies make the genetic contribution even clearer: identical twins share peanut allergy about 64% of the time, while fraternal twins share it only about 7% of the time. Based on those numbers, researchers estimate that genetics account for roughly 82% of the risk for peanut allergy.
Several gene families have been linked to nut allergy specifically. Variations in the HLA gene family, which controls how the immune system identifies foreign proteins, show up more frequently in people with peanut and tree nut allergies. Variations in genes that regulate immune signaling (including those involved in producing allergy-promoting molecules) and in a gene called FOXP3, which helps keep immune responses in check, have also been associated with food allergy. None of these genes act alone. They interact with each other and with environmental exposures to determine whether a person develops an allergy.
Skin Exposure vs. Eating: The Dual Allergen Hypothesis
One of the more important discoveries in food allergy research is that where the body first encounters a food protein matters enormously. The dual allergen exposure hypothesis, proposed by researcher Gideon Lack, explains that when nut proteins contact an infant’s skin, especially skin that’s inflamed from eczema, the immune system is more likely to treat them as threats. But when the same proteins are eaten, the gut tends to develop tolerance.
Animal studies have confirmed this pattern: mice exposed to peanut proteins through disrupted skin developed strong allergic immune responses. In humans, peanut allergy has been linked to immune cells that carry skin-homing markers, suggesting that sensitization happened through the skin rather than through the digestive tract. This is why eczema in infancy is one of the strongest risk factors for developing a peanut allergy. The damaged skin barrier lets food proteins slip through and prime the immune system in the wrong direction.
This insight has reshaped prevention advice. Controlling eczema in infants and introducing peanut-containing foods by mouth early in life are now seen as two sides of the same coin: reducing skin sensitization while building oral tolerance.
Early Introduction Dramatically Reduces Risk
The National Institute of Allergy and Infectious Diseases now recommends introducing peanut-containing foods to high-risk infants (those with severe eczema or egg allergy) as early as 4 to 6 months of age. For infants with mild to moderate eczema, introduction around 6 months is suggested. Infants with no eczema or food allergies can have peanut-containing foods introduced freely alongside other solids.
These guidelines are built on striking clinical trial results. Among infants who had no initial skin sensitivity to peanut, those who ate peanut regularly had a peanut allergy rate of just 1.9% by age 5, compared to 13.7% in children who avoided peanut. That’s an 86% relative reduction in risk. Even among infants who already showed some skin sensitivity to peanut at enrollment, early consumption still cut the allergy rate by 70%. The previous approach of delaying nut exposure likely contributed to rising allergy rates over the past two decades.
Gut Bacteria and the Hygiene Hypothesis
The sharp increase in nut allergies over recent decades points to environmental causes, since genetics don’t shift that fast. One leading explanation is the hygiene hypothesis: the idea that modern, cleaner lifestyles limit the microbial exposure children need for normal immune development. A refined version, sometimes called the microflora hypothesis, focuses specifically on how reduced bacterial diversity in the infant gut disrupts immune system calibration.
Research has found that lower gut microbiota diversity during infancy is associated with allergic disease later in childhood. Household pets and older siblings appear to be protective, likely because they introduce a wider variety of environmental microbes that help populate the infant gut. The protective effect isn’t as simple as “more bacteria equals fewer allergies,” though. It appears to involve complex shifts in the types of bacterial communities present, not just overall diversity. Children raised in highly sanitized environments may miss out on the microbial signals that teach the immune system to tolerate harmless proteins like those in food.
Cross-Reactivity With Pollen
Some people develop nut-related symptoms not because of a primary nut allergy but because of cross-reactivity with pollen. If you’re allergic to birch tree pollen, a common springtime allergen, your immune system may also react to proteins in peanuts, almonds, and hazelnuts that look structurally similar. This typically causes oral allergy syndrome: itching or tingling in the mouth and throat after eating these nuts, especially raw.
These reactions are usually milder than a true nut allergy and are often limited to the mouth. However, the American Academy of Allergy, Asthma and Immunology notes that mouth symptoms from nuts can sometimes signal a more serious underlying allergy, so they shouldn’t be dismissed.
How Cooking Methods Change Allergenicity
The way nuts are processed affects how allergenic they are, which may help explain geographic differences in allergy rates. Roasting peanuts, the dominant preparation method in Western countries, changes the structure of key allergenic proteins in ways that make them harder to digest and more reactive to the immune system. Boiling, which is more common in parts of East Asia, has the opposite effect. It breaks down protein structures and makes them easier for the stomach to dismantle before they can trigger an immune response.
Specifically, roasting alters a major peanut allergen so that it resists digestion in stomach acid, allowing it to survive long enough to interact with immune cells in the gut. Boiled peanut proteins, by contrast, break down significantly within seconds of simulated digestion. This doesn’t mean boiling makes peanuts safe for someone with a confirmed allergy, but it may partially explain why peanut allergy is far less common in countries where boiling is the standard preparation.
Can Children Outgrow Nut Allergies?
Peanut allergy is more persistent than many other childhood food allergies. A population-based study tracking children to age 6 found that about 29% of those with peanut allergy outgrew it naturally, compared to 89% for egg allergy. That means the majority of children diagnosed with peanut allergy will carry it into later childhood and potentially into adulthood. The adult peanut allergy rate in the U.S. was estimated at 3% in 2015 to 2016, up from less than 1% in 1999, reflecting both rising incidence and the persistence of childhood cases.
Tree nut allergies are generally considered even less likely to be outgrown than peanut allergy, though large longitudinal studies with precise resolution rates are less available. For families managing a child’s nut allergy, periodic re-evaluation with supervised food challenges remains the only reliable way to determine whether the allergy has resolved.